Literature DB >> 19386802

Gene expression of nucleic acid-sensing pattern recognition receptors in children hospitalized for respiratory syncytial virus-associated acute bronchiolitis.

Carolina Scagnolari1, Fabio Midulla, Alessandra Pierangeli, Corrado Moretti, Enea Bonci, Rosaria Berardi, Daniela De Angelis, Carla Selvaggi, Paola Di Marco, Enrico Girardi, Guido Antonelli.   

Abstract

Given the critical role of pattern recognition receptors (PRRs) in acid nucleic recognition in the initiation of innate immunity and the orchestration of adaptive immunity, the aim of this study was to determine whether any heterogeneity of PRR expression in the airway tracts of infants with respiratory syncytial virus (RSV) infection might explain the broad clinical spectrum of RSV-associated bronchiolitis in infants. For this purpose, the levels of melanoma differentiation-associated protein-5 (MDA-5), retinoic acid inducible gene-1 (RIG-1), and Toll-like receptor 3 (TLR-3), TLR-7, TLR-8, and TLR-9 mRNAs were evaluated, using TaqMan quantitative reverse transcription-PCR, in cells from nasopharyngeal washes collected from 157 infants suffering from acute bronchiolitis whether or not they were associated with respiratory viruses. High interindividual variability was observed in both virus-positive and -negative infants; however, the relative gene expression levels of MDA-5, RIG-1, TLR-7, and TLR-8 were significantly higher in the virus-infected group, whereas the expression levels of TLR-3 and TLR-9 were not significantly different. The differences in the gene expression of MDA-5, RIG-1, TLR-7, and TLR-8 were more evident in infants with RSV infection than in those with bocavirus or rhinovirus infection. In RSV-infected infants, PRR-mRNA levels also were analyzed in relation to interferon protein levels, viral load, clinical severity, days of hospitalization, age, and body weight. A significant positive correlation was observed only between RSV viral load and RIG-1 mRNA levels. These findings provide the first direct evidence that, in infants with respiratory virus-associated bronchiolitis, especially RSV, there are substantial changes in PRR gene expression; this likely is an important determinant of the clinical outcome of bronchiolitis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19386802      PMCID: PMC2691037          DOI: 10.1128/CVI.00445-08

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  45 in total

1.  Beta-chemokines, but neither T helper type 1 nor T helper type 2 cytokines, correlate with severity of illness during respiratory syncytial virus infection.

Authors:  Robert C Welliver; Roberto P Garofalo; Pearay L Ogra
Journal:  Pediatr Infect Dis J       Date:  2002-05       Impact factor: 2.129

2.  Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression.

Authors:  Brian D Rudd; Ezra Burstein; Colin S Duckett; Xiaoxia Li; Nicholas W Lukacs
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

3.  CD14-dependent lipopolysaccharide-induced beta-defensin-2 expression in human tracheobronchial epithelium.

Authors:  M N Becker; G Diamond; M W Verghese; S H Randell
Journal:  J Biol Chem       Date:  2000-09-22       Impact factor: 5.157

4.  Illness severity, viral shedding, and antibody responses in infants hospitalized with bronchiolitis caused by respiratory syncytial virus.

Authors:  Peter F Wright; William C Gruber; Melissa Peters; George Reed; Yuwei Zhu; Frances Robinson; Shanita Coleman-Dockery; Barney S Graham
Journal:  J Infect Dis       Date:  2002-04-01       Impact factor: 5.226

5.  A multicenter, randomized, double-blind, controlled trial of nebulized epinephrine in infants with acute bronchiolitis.

Authors:  Claire Wainwright; Luis Altamirano; Marise Cheney; Joyce Cheney; Scott Barber; Darrell Price; Sue Moloney; Ann Kimberley; Nick Woolfield; Susan Cadzow; Frank Fiumara; Peter Wilson; Steve Mego; Dianne VandeVelde; Sharon Sanders; Peter O'Rourke; Paul Francis
Journal:  N Engl J Med       Date:  2003-07-03       Impact factor: 91.245

Review 6.  Pathogenesis and treatment of bronchiolitis.

Authors:  R A Lugo; M C Nahata
Journal:  Clin Pharm       Date:  1993-02

7.  Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis.

Authors:  Julian P Legg; Imran R Hussain; Jill A Warner; Sebastian L Johnston; John O Warner
Journal:  Am J Respir Crit Care Med       Date:  2003-05-28       Impact factor: 21.405

8.  Simultaneous detection, subgrouping, and quantitation of respiratory syncytial virus A and B by real-time PCR.

Authors:  Aizhong Hu; Melissa Colella; John S Tam; Ruth Rappaport; Sheau-Mei Cheng
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

9.  Quantitation of respiratory syncytial virus RNA in nasal aspirates of children by real-time RT-PCR assay.

Authors:  M Gueudin; A Vabret; J Petitjean; S Gouarin; J Brouard; F Freymuth
Journal:  J Virol Methods       Date:  2003-04       Impact factor: 2.014

10.  Human bocavirus infection in hospitalized children in Italy.

Authors:  Alessandra Pierangeli; Carolina Scagnolari; Simona Trombetti; Rosanna Grossi; Massimo Battaglia; Corrado Moretti; Fabio Midulla; Guido Antonelli
Journal:  Influenza Other Respir Viruses       Date:  2008-09       Impact factor: 4.380

View more
  27 in total

1.  Structural basis for IFN antagonism by human respiratory syncytial virus nonstructural protein 2.

Authors:  Jingjing Pei; Nicole D Wagner; Angela J Zou; Srirupa Chatterjee; Dominika Borek; Aidan R Cole; Preston J Kim; Christopher F Basler; Zbyszek Otwinowski; Michael L Gross; Gaya K Amarasinghe; Daisy W Leung
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-09       Impact factor: 11.205

2.  Induction and Antagonism of Antiviral Responses in Respiratory Syncytial Virus-Infected Pediatric Airway Epithelium.

Authors:  Rémi Villenave; Lindsay Broadbent; Isobel Douglas; Jeremy D Lyons; Peter V Coyle; Michael N Teng; Ralph A Tripp; Liam G Heaney; Michael D Shields; Ultan F Power
Journal:  J Virol       Date:  2015-09-30       Impact factor: 5.103

3.  p53-responsive TLR8 SNP enhances human innate immune response to respiratory syncytial virus.

Authors:  Daniel Menendez; Joyce Snipe; Jacqui Marzec; Cynthia L Innes; Fernando P Polack; Mauricio T Caballero; Shepherd H Schurman; Steven R Kleeberger; Michael A Resnick
Journal:  J Clin Invest       Date:  2019-11-01       Impact factor: 14.808

4.  Interleukin-32 isoforms: expression, interaction with interferon-regulated genes and clinical significance in chronically HIV-1-infected patients.

Authors:  Katia Monteleone; Pierluigi Di Maio; Giulia Cacciotti; Francesca Falasca; Maurizio Fraulo; Mario Falciano; Ivano Mezzaroma; Gabriella D'Ettorre; Ombretta Turriziani; Carolina Scagnolari
Journal:  Med Microbiol Immunol       Date:  2014-02-20       Impact factor: 3.402

5.  TLR4 Asp299Gly and Thr399Ile polymorphisms: no impact on human immune responsiveness to LPS or respiratory syncytial virus.

Authors:  Renée N Douville; Yuriy Lissitsyn; Aaron F Hirschfeld; Allan B Becker; Anita L Kozyrskyj; Joel Liem; Nathalie Bastien; Yan Li; Rachel E Victor; Mehtab Sekhon; Stuart E Turvey; Kent T HayGlass
Journal:  PLoS One       Date:  2010-08-10       Impact factor: 3.240

Review 6.  The innate immune response to RSV: Advances in our understanding of critical viral and host factors.

Authors:  Yan Sun; Carolina B López
Journal:  Vaccine       Date:  2016-09-28       Impact factor: 3.641

Review 7.  Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology.

Authors:  John S Tregoning; Jürgen Schwarze
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

Review 8.  The Human Immune Response to Respiratory Syncytial Virus Infection.

Authors:  Clark D Russell; Stefan A Unger; Marc Walton; Jürgen Schwarze
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

9.  Decreased pattern recognition receptor signaling, interferon-signature, and bactericidal/permeability-increasing protein gene expression in cord blood of term low birth weight human newborns.

Authors:  Vikas Vikram Singh; Sudhir Kumar Chauhan; Richa Rai; Ashok Kumar; Shiva M Singh; Geeta Rai
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

10.  Perinatal lamb model of respiratory syncytial virus (RSV) infection.

Authors:  Rachel J Derscheid; Mark R Ackermann
Journal:  Viruses       Date:  2012-10-23       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.